Tony R. Zerbe

1.4k total citations
38 papers, 1.1k citations indexed

About

Tony R. Zerbe is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Transplantation. According to data from OpenAlex, Tony R. Zerbe has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 9 papers in Transplantation. Recurrent topics in Tony R. Zerbe's work include Transplantation: Methods and Outcomes (24 papers), Viral Infections and Immunology Research (13 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Tony R. Zerbe is often cited by papers focused on Transplantation: Methods and Outcomes (24 papers), Viral Infections and Immunology Research (13 papers) and Renal Transplantation Outcomes and Treatments (8 papers). Tony R. Zerbe collaborates with scholars based in United States and Japan. Tony R. Zerbe's co-authors include William P. Follansbee, Robert L. Kormos, Thomas A. Medsger, Vincent C. Arena, Robert L. Hardesty, Bartley P. Griffith, René J. Duquesnoy, Demetris Aj, Barry F. Uretsky and Bruce S. Rabin and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Tony R. Zerbe

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tony R. Zerbe United States 19 610 327 275 212 155 38 1.1k
A Zerbe United States 4 1.0k 1.7× 431 1.3× 416 1.5× 193 0.9× 45 0.3× 9 1.3k
E. Jeanne O'Sullivan United States 7 399 0.7× 96 0.3× 245 0.9× 97 0.5× 137 0.9× 11 953
Kathleen M. Heidler United States 16 509 0.8× 108 0.3× 174 0.6× 411 1.9× 50 0.3× 24 1.1k
Salim Aziz United States 21 565 0.9× 151 0.5× 160 0.6× 60 0.3× 69 0.4× 48 1.1k
A. Kostakis Greece 19 249 0.4× 120 0.4× 144 0.5× 106 0.5× 44 0.3× 63 977
Jussi Tikkanen Canada 24 1.2k 2.0× 149 0.5× 514 1.9× 125 0.6× 51 0.3× 91 1.7k
Thomas F. Flavin United States 15 829 1.4× 718 2.2× 72 0.3× 117 0.6× 62 0.4× 22 1.1k
Danna E. Johnson United States 13 649 1.1× 253 0.8× 33 0.1× 65 0.3× 74 0.5× 25 1.0k
Steven Zangwill United States 17 621 1.0× 203 0.6× 278 1.0× 37 0.2× 76 0.5× 66 946
Hironori Izutani Japan 19 639 1.0× 406 1.2× 48 0.2× 83 0.4× 27 0.2× 101 1.1k

Countries citing papers authored by Tony R. Zerbe

Since Specialization
Citations

This map shows the geographic impact of Tony R. Zerbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony R. Zerbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony R. Zerbe more than expected).

Fields of papers citing papers by Tony R. Zerbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony R. Zerbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony R. Zerbe. The network helps show where Tony R. Zerbe may publish in the future.

Co-authorship network of co-authors of Tony R. Zerbe

This figure shows the co-authorship network connecting the top 25 collaborators of Tony R. Zerbe. A scholar is included among the top collaborators of Tony R. Zerbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony R. Zerbe. Tony R. Zerbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borovetz, Harvey S., N. Ramasamy, Tony R. Zerbe, & Peer M. Portner. (1995). Evaluation of an Implantable Ventricular Assist System for Humans With Chronic Refractory Heart Failure. ASAIO Journal. 41(1). 42–48. 3 indexed citations
2.
Uretsky, Barry F., et al.. (1994). Increased plasma atrial natriuretic peptide levels after heart transplant: Relation to ventricular expression and severity of rejection. American Heart Journal. 128(4). 769–773. 4 indexed citations
3.
Follansbee, William P., Tony R. Zerbe, & Thomas A. Medsger. (1993). Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association. American Heart Journal. 125(1). 194–203. 145 indexed citations
4.
Kaufman, Christina L., Adriana Zeevi, Tony R. Zerbe, & René J. Duquesnoy. (1992). IL-2-AUGMENTED PRIMED-LYMPHOCYTE TEST RESPONSES OF LYMPHOCYTES CULTURED FROM ENDOMYOCARDIAL BIOPSIES FROM HEART TRANSPLANT PATIENTS. Transplantation. 54(6). 1111–1111. 3 indexed citations
5.
Uretsky, Barry F., P S Reddy, Bart G. Denys, et al.. (1992). Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. The American Journal of Cardiology. 69(14). 1234–1237. 25 indexed citations
6.
Vitolo, Domenico, et al.. (1992). Expression of mRNA for cytokines in tumor‐infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. International Journal of Cancer. 51(4). 573–580. 64 indexed citations
7.
Butler, K., Harvey S. Borovetz, Robert L. Kormos, et al.. (1992). Development of an Axial Flow Blood Pump LVAS. ASAIO Journal. 38(3). M296–M300. 28 indexed citations
8.
Zeevi, A., R. Venkataramanan, M Alessiani, et al.. (1991). In vitro assessment of FK 506 immunosuppressive activity in transplant patients.. PubMed. 23(6). 2897–9. 6 indexed citations
9.
10.
Zerbe, Tony R., Vincent C. Arena, Robert L. Kormos, et al.. (1991). HISTOCOMPATIBILITY AND OTHER RISK FACTORS FOR HISTOLOGICAL REJECTION OF HUMAN CARDIAC ALLOGRAFTS DURING THE FIRST THREE MONTHS FOLLOWING TRANSPLANTATION. Transplantation. 52(3). 485–490. 32 indexed citations
11.
Curtiss, Edward I., et al.. (1990). The scalar electrocardiogram of the orthotopic heart transplant recipient. American Heart Journal. 119(4). 917–923. 18 indexed citations
12.
Kaufman, Christina L., Adriana Zeevi, Robert L. Kormos, et al.. (1990). Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Human Immunology. 28(2). 228–236. 11 indexed citations
13.
Oguma, S, Tony R. Zerbe, Barbara F. Banner, et al.. (1989). Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms.. PubMed. 21(1 Pt 2). 2203–7. 24 indexed citations
14.
Zerbe, Tony R.. (1989). Contrast of mediators: identification of cells and cytokines in human heart tissue with acute rejection and myocarditis.. PubMed. 21(1 Pt 1). 443–4. 3 indexed citations
15.
Aj, Demetris, et al.. (1989). Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations.. PubMed. 21(4). 3667–9. 86 indexed citations
16.
Zerbe, Tony R., Christina Kaufmann, Yolonda L. Colson, & René J. Duquesnoy. (1988). Associations of HLA-A, B, DR antigens with primary disease in cardiac allograft recipients. The American Journal of Cardiology. 61(15). 1359–1361. 17 indexed citations
17.
Trento, Alfredo, Robert L. Hardesty, Bartley P. Griffith, et al.. (1988). Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. Journal of Thoracic and Cardiovascular Surgery. 95(1). 37–41. 51 indexed citations
18.
Cox, Catherine, et al.. (1987). EKTACHEM BILIRUBIN FRACTION Bc AS A PREDICTOR OF LIVER TRANSPLANT REJECTION. Transplantation. 44(4). 536–539. 11 indexed citations
19.
Klein, Irwin, Chull Hong, & Tony R. Zerbe. (1987). Myosin content and myosin isoenzyme distribution in the heterotopic rat heart allograft. Journal of Molecular and Cellular Cardiology. 19(9). 917–921. 10 indexed citations
20.
Brasile, Lauren, et al.. (1985). IDENTIFICATION OF THE ANTIBODY TO VASCULAR ENDOTHELIAL CELLS IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION. Transplantation. 40(6). 672–674. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Zerbe Breakdown of academic impact, for papers by E. Jeanne O'Sullivan Breakdown of academic impact, for papers by Kathleen M. Heidler Breakdown of academic impact, for papers by Salim Aziz Breakdown of academic impact, for papers by A. Kostakis Breakdown of academic impact, for papers by Jussi Tikkanen Breakdown of academic impact, for papers by Thomas F. Flavin Breakdown of academic impact, for papers by Danna E. Johnson Breakdown of academic impact, for papers by Steven Zangwill Breakdown of academic impact, for papers by Hironori Izutani
Rankless by CCL
2026